Ballast Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.31M Buy
4,427
+434
+11% +$443K 1% 24
2026
Q1
$3.67M Sell
3,993
-5
-0.1% -$5.07K 0.85% 24
2025
Q4
$4.3M Sell
3,998
-363
-8% -$347K 1.01% 21
2025
Q3
$3.33M Buy
4,361
+31
+0.7% +$23.1K 0.81% 24
2025
Q2
$3.38M Buy
4,330
+24
+0.6% +$18.6K 0.88% 23
2025
Q1
$3.56M Buy
4,306
+60
+1% +$49.9K 1.01% 20
2024
Q4
$3.28M Sell
4,246
-121
-3% -$100K 0.94% 21
2024
Q3
$3.87M Sell
4,367
-65
-1% -$58.4K 1.1% 18
2024
Q2
$4.01M Sell
4,432
-143
-3% -$114K 1.24% 18
2024
Q1
$3.56M Sell
4,575
-61
-1% -$43.4K 1.12% 18
2023
Q4
$2.7M Buy
4,636
+501
+12% +$292K 0.93% 19
2023
Q3
$2.22M Sell
4,135
-812
-16% -$418K 0.88% 19
2023
Q2
$2.32M Buy
4,947
+38
+0.8% +$15.9K 0.89% 19
2023
Q1
$1.69M Buy
4,909
+113
+2% +$38.1K 0.69% 21
2022
Q4
$1.75M Sell
4,796
-192
-4% -$68.1K 0.77% 22
2022
Q3
$1.61M Sell
4,988
-307
-6% -$97.3K 0.79% 19
2022
Q2
$1.72M Sell
5,295
-286
-5% -$85.8K 0.8% 19
2022
Q1
$1.6M Buy
5,581
+375
+7% +$96.5K 0.62% 22
2021
Q4
$1.44M Sell
5,206
-373
-7% -$94.6K 0.56% 29
2021
Q3
$1.29M Buy
5,579
+79
+1% +$19.5K 0.54% 27
2021
Q2
$1.26M Buy
5,500
+657
+14% +$132K 0.53% 27
2021
Q1
$904K Sell
4,843
-11
-0.2% -$2.15K 0.43% 33
2020
Q4
$819K Buy
4,854
+68
+1% +$10.2K 0.42% 31
2020
Q3
$708K Sell
4,786
-10
-0.2% -$1.55K 0.4% 36
2020
Q2
$787K Sell
4,796
-226
-5% -$34.7K 0.5% 36
2020
Q1
$696K Buy
5,022
+109
+2% +$15K 0.49% 35
2019
Q4
$645K Buy
4,913
+108
+2% +$12.5K 0.36% 48
2019
Q3
$537K Buy
4,805
+44
+0.9% +$4.9K 0.33% 54
2019
Q2
$527K Sell
4,761
-41
-0.9% -$4.83K 0.33% 53
2019
Q1
$623K Buy
4,802
+220
+5% +$26.8K 0.41% 47
2018
Q4
$530K Sell
4,582
-9
-0.2% -$1K 0.41% 44
2018
Q3
$493K Sell
4,591
-298
-6% -$29.8K 0.34% 51
2018
Q2
$417K Buy
4,889
+250
+5% +$20.5K 0.32% 51
2018
Q1
$359K Buy
4,639
+838
+22% +$67.5K 0.29% 60
2017
Q4
$321K Buy
+3,801
New +$323K 0.27% 62

Other funds holding LLY

Ballast Inc's LLY Position: Q2 2026 in Review

Ballast Inc increased its Eli Lilly (LLY) stake by 11% in Q2 2026, buying an estimated $443K and bringing the position to 4,427 shares worth $5.31M. The position accounts for 1% of the portfolio, ranked #24.

Ballast Inc first reported a position in LLY in Q4 2017 and has held it in 35 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ballast Inc held 4,427 shares of Eli Lilly worth $5.31M as of Q2 2026.
  • Ballast Inc bought 434 Eli Lilly shares in Q2 2026, an estimated $443K.
  • Eli Lilly made up 1% of Ballast Inc's portfolio in Q2 2026, its #24 holding.
  • Ballast Inc first reported a position in Eli Lilly in Q4 2017 and has held it in 35 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ballast Inc's 13F filing for Q2 2026, filed 10 Jul 2026.